Browsing Tag
Oncology
318 posts
LIPAC Oncology takes NMIBC treatment TBC-1002 into phase 2 A trial
Investigational NMIBC treatment TBC-1002 : LIPAC Oncology said that it has wrapped up a phase 1 clinical trial…
October 27, 2019
The Pritzker Organization invests in AI-driven Systems Oncology
Systems Oncology, which uses big data and AI to discover scientific insights into cancer biology, has secured an…
October 23, 2019
Varian introduces Ethos therapy – AI-powered cancer care delivery solution
Ethos therapy Varian : Varian, a cancer care technologies developer, has introduced Ethos therapy, an artificial intelligence (AI)-powered…
September 16, 2019
Sanofi, Regeneron secure Libtayo EMA approval for a type of skin cancer
Libtayo EMA approval : The European Commission has given conditional approval for Libtayo (cemiplimab) for the treatment of…
July 21, 2019
Boehringer Ingelheim acquires Swiss biotech company AMAL Therapeutics
Boehringer Ingelheim acquisition of AMAL Therapeutics : German pharma company Boehringer Ingelheim has acquired Swiss biotech company AMAL…
July 16, 2019
Merck to acquire US biopharma company Peloton Therapeutics in $2.2bn deal
Merck acquisition of Peloton : Pharma giant Merck is set to acquire US biopharma company Peloton Therapeutics in…
July 14, 2019
Pixuvri EMA approval : Servier NHL drug secures standard marketing authorization in Europe
Pixuvri EMA approval : French pharma company Servier has secured full approval for Pixuvri (pixantrone) from the European…
June 13, 2019
Pharma giants bag Lynparza EMA approval for metastatic breast cancer
Lynparza EMA approval : Pharma giants AstraZeneca and MSD have secured an expansion of the European Medical Agency’s…
May 19, 2019
Genentech gets Kadcyla FDA approval for post-surgery treatment of HER2+ EBC
Kadcyla FDA approval : Roche subsidiary Genentech has secured approval from the US Food and Drug Administration (FDA)…
May 5, 2019
Ibrance FDA approval : Pfizer breast cancer drug approved for metastatic breast cancer in men
New Ibrance FDA approval : The US Food and Drug Administration (FDA) has extended the approval of Pfizer…
April 17, 2019